Non-Canonical NF-κB Signaling Stratifies LGG into Subtypes with Distinct Molecular and Cellular Characteristic and Survival Expectancy

References

• Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-1
   PubMed Web of Science ®Google Scholar
• Suzuki H, Aoki K, Chiba K, et al. Mutational landscape and clonal architecture in grade ii and iii gliomas. Nat Genet. 2015;47(5):458–468. doi:10.1038/ng.3273
   PubMed Web of Science ®Google Scholar
• Chan AK, Yao Y, Zhang Z, et al. Combination genetic signature stratifies lower-grade gliomas better than histological grade. Oncotarget. 2015;6(25):20885–20901. doi:10.18632/oncotarget.4928
   PubMedGoogle Scholar
• Liu XY, Gerges N, Korshunov A, et al. Frequent atrx mutations and loss of expression in adult diffuse astrocytic tumors carrying idh1/idh2 and tp53 mutations. Acta Neuropathol. 2012;124(5):615–625. doi:10.1007/s00401-012-1031-3
   PubMed Web of Science ®Google Scholar
• Weller M, Stupp R, Hegi ME, et al. Personalized care in neuro-oncology coming of age: why we need mgmt and 1p/19q testing for malignant glioma patients in clinical practice. Neuro Oncol. 2012;14(Suppl 4):iv100–iv108. doi:10.1093/neuonc/nos206
   PubMed Web of Science ®Google Scholar
• Fridman WH, Galon J, Pagès F, Tartour E, Sautès-Fridman C, Kroemer G. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res. 2011;71(17):5601–5605. doi:10.1158/0008-5472.Can-11-1316
   PubMed Web of Science ®Google Scholar
• Murray PJ. Macrophage polarization. Annu Rev Physiol. 2017;79:541–566. doi:10.1146/annurev-physiol-022516-034339
   PubMed Web of Science ®Google Scholar
• Sørensen MD, Dahlrot RH, Boldt HB, Hansen S, Kristensen BW. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype. Neuropathol Appl Neurobiol. 2018;44(2):185–206. doi:10.1111/nan.12428
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Newman AM, Liu CL, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938–945. doi:10.1038/nm.3909
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. Nf-κb, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–324. doi:10.1038/nri.2017.142
   PubMed Web of Science ®Google Scholar
• Porta C, Rimoldi M, Raes G, et al. Tolerance and m2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappab. Proc Natl Acad Sci USA. 2009;106(35):14978–14983. doi:10.1073/pnas.0809784106
   PubMed Web of Science ®Google Scholar
• Tu S, Bhagat G, Cui G, et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008;14(5):408–419. doi:10.1016/j.ccr.2008.10.011
   PubMed Web of Science ®Google Scholar
• Hopewell EL, Zhao W, Fulp WJ, et al. Lung tumor nf-κb signaling promotes t cell-mediated immune surveillance. J Clin Invest. 2013;123(6):2509–2522. doi:10.1172/jci67250
   PubMed Web of Science ®Google Scholar
• Dejardin E. The alternative nf-kappab pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol. 2006;72(9):1161–1179. doi:10.1016/j.bcp.2006.08.007
   PubMed Web of Science ®Google Scholar
• Sun SC. The noncanonical nf-κb pathway. Immunol Rev. 2012;246(1):125–140. doi:10.1111/j.1600-065X.2011.01088.x
   PubMed Web of Science ®Google Scholar
• Yu J, Zhou X, Nakaya M, Jin W, Cheng X, Sun SC. T cell-intrinsic function of the noncanonical nf-κb pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis. J Immunol. 2014;193(1):422–430. doi:10.4049/jimmunol.1303237
   PubMed Web of Science ®Google Scholar
• Li Y, Wang H, Zhou X, et al. Cell intrinsic role of nf-κb-inducing kinase in regulating t cell-mediated immune and autoimmune responses. Sci Rep. 2016;6:22115. doi:10.1038/srep22115
   PubMed Web of Science ®Google Scholar
• Gerondakis S, Grumont R, Gugasyan R, et al. Unravelling the complexities of the nf-|[kappa]|b signalling pathway using mouse knockout and transgenic models. Oncogene. 2006;25(51):6781–6799. doi:10.1038/sj.onc.1209944
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang KN, Wang Q, et al. Chinese glioma genome atlas (cgga): a comprehensive resource with functional genomic data from Chinese glioma patients - ScienceDirect. Genom Proteom Bioinform. 2021;19(1):12.
   Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713
   PubMed Web of Science ®Google Scholar
• Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–262. doi:10.1016/j.celrep.2016.12.019
   PubMed Web of Science ®Google Scholar
• Hakimi AA, Reznik E, Lee C-H, et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell. 2016;29(1):104–116. doi:10.1016/j.ccell.2015.12.004
   PubMed Web of Science ®Google Scholar
• Ott PA, Bang YJ, Piha-Paul SA, et al. T-cell–inflamed gene-expression profile, programmed death ligand 1 expression, and tumor mutational burden predict efficacy in patients treated with pembrolizumab across 20 cancers: keynote-028. J Clin Oncol. 2019;37(4):318–327. doi:10.1200/JCO.2018.78.2276
   PubMed Web of Science ®Google Scholar
• Martínez-Jiménez F, Muiños F, Sentís I, et al. A compendium of mutational cancer driver genes. Nat Rev Cancer. 2020;20(10):555–572. doi:10.1038/s41568-020-0290-x
   PubMed Web of Science ®Google Scholar
• Yan H, Parsons DW, Jin G, et al. Idh1 and idh2 mutations in gliomas. N Engl J Med. 2009;360(8):765–773. doi:10.1056/NEJMoa0808710
   PubMed Web of Science ®Google Scholar
• Shostak K, Chariot A. Egfr and nf-κb: partners in cancer. Trends Mol Med. 2015;21(6):385–393. doi:10.1016/j.molmed.2015.04.001
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Agrawal N, Jiao Y, et al. Mutations in cic and fubp1 contribute to human oligodendroglioma. Science. 2011;333(6048):1453–1455. doi:10.1126/science.1210557
   PubMed Web of Science ®Google Scholar
• Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 2015;25(4):198–213. doi:10.1016/j.tcb.2014.11.006
   PubMed Web of Science ®Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi:10.1038/nm.3394
   PubMed Web of Science ®Google Scholar
• Bao B, Thakur A, Li Y, et al. The immunological contribution of nf-κb within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent. Biochimica et Biophysica Acta. 2012;1825(2):160–172. doi:10.1016/j.bbcan.2011.11.002
   PubMed Web of Science ®Google Scholar
• Hoesel B, Schmid JA. The complexity of nf-κb signaling in inflammation and cancer. Mol Cancer. 2013;12(1):1–15.
   PubMed Web of Science ®Google Scholar
• Jones RB, Ndhlovu LC, Barbour JD, et al. Tim-3 expression defines a novel population of dysfunctional t cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med. 2008;205(12):2763–2779. doi:10.1084/jem.20081398
   PubMed Web of Science ®Google Scholar
• Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting tim-3 and pd-1 pathways to reverse t cell exhaustion and restore anti-tumor immunity. J Exp Med. 2010;207(10):2187–2194. doi:10.1084/jem.20100643
   PubMed Web of Science ®Google Scholar
• Ayers M, Lunceford J, Nebozhyn M, et al. Ifn-γ–related mRNA profile predicts clinical response to pd-1 blockade. J Clin Investig. 2017;127(8):2930–2940. doi:10.1172/JCI91190
   PubMed Web of Science ®Google Scholar
• Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer. 2020;20(1):12–25. doi:10.1038/s41568-019-0224-7
   PubMed Web of Science ®Google Scholar
• Duran CL, Lee DW, Jung JU, et al. NIK regulates MT1-MMP activity and promotes glioma cell invasion independently of the canonical nf-κb pathway. Oncogenesis. 2016;5(6):e231. doi:10.1038/oncsis.2016.39
   PubMed Web of Science ®Google Scholar
• Tchoghandjian A, Jennewein C, Eckhardt I, Rajalingam K, Fulda S. Identification of non-canonical nf-κb signaling as a critical mediator of smac mimetic-stimulated migration and invasion of glioblastoma cells. Cell Death Dis. 2013;4(3):e564. doi:10.1038/cddis.2013.70
   PubMed Web of Science ®Google Scholar
• Vidyarthi A, Agnihotri T, Khan N, et al. Predominance of m2 macrophages in gliomas leads to the suppression of local and systemic immunity. Cancer Immunol Immunother. 2019;68(12):1995–2004. doi:10.1007/s00262-019-02423-8
   PubMed Web of Science ®Google Scholar
• Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol. 2006;8(3):261–279. doi:10.1215/15228517-2006-008
   PubMed Web of Science ®Google Scholar
• Wolf Y, Anderson AC, Kuchroo VK. Tim3 comes of age as an inhibitory receptor. Nat Rev Immunol. 2020;20(3):173–185. doi:10.1038/s41577-019-0224-6
   PubMed Web of Science ®Google Scholar
• Fourcade J, Sun Z, Benallaoua M, et al. Upregulation of tim-3 and pd-1 expression is associated with tumor antigen-specific cd8+ t cell dysfunction in melanoma patients. J Exp Med. 2010;207(10):2175–2186. doi:10.1084/jem.20100637
   PubMed Web of Science ®Google Scholar
• Anfray C, Ummarino A, Andón FT, Allavena P. Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses. Cells. 2020;9(1):46.
   Web of Science ®Google Scholar
• Belgiovine C, Digifico E, Anfray C, Ummarino A, Torres andón F. Targeting tumor-associated macrophages in anti-cancer therapies: convincing the traitors to do the right thing. J Clin Med. 2020;9(10):3226.
   PubMed Web of Science ®Google Scholar